NRX Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Wilmington, DE
SEC filing record 1 source field available
Fiscal year end
31 December
NRX Pharmaceuticals, Inc. has filed 467 SEC EDGAR filings since 13 Oct 2017

SEC filing history

Showing 126-150 of 467 matching filings.

Per page
25
Current page
6
3

OWNERSHIP DOCUMENT

Filing date
19 Sep 2023
Reporting date
13 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Sep 2023
Reporting date
30 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Sep 2023
Reporting date
30 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-265492

424B3

Filing date
31 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
24 Aug 2023
Reporting date
23 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
23 Aug 2023
Reporting date
22 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-265492

424B5

Filing date
14 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-265492

424B5

Filing date
08 Jun 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-38302

FORM 8-K/A

Filing date
07 Jun 2023
Reporting date
06 Jun 2023
Next action
Verify source filing
10-K/A File 001-38302

FORM 10-K/A

Filing date
26 May 2023
Reporting date
31 Dec 2022
Next action
Verify source filing
10-K/A File 001-38302

FORM 10-K/A

Filing date
01 May 2023
Reporting date
31 Dec 2022
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .